Two people researching the same compound are rarely candidates for the same approach, and the variables that matter are not visible in a search result
Since glutathione deficiency and oxidative stress often contribute to nervous system conditions, glutathione supplementation may reduce symptoms and slow disease progression
However, Epithalon remains investigational with no FDA approval, most research conducted in Russia with limited Western replication, long-term human safety data sparse, optimal dosing protocols still debated, and mechanisms not fully understood
Color figures are included in the HTML version of this manuscript Additional information Edited by A Finazzi-Agro Supplementary Information accompanies the paper on Cell Death and Differentiation website ( Supplementary information Rights and permissions About this article Cite this article Franco, R., Cidlowski, J